NCT02520297

A Pilot Study of TRV130 for the Treatment of Fracture Pain

A Phase 2, Open-label Pilot Study of TRV130 for the Treatment of Moderate to Severe Acute Pain Associated With Long Bone Fracture

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Trevena Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.

Detailed description

This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of moderate to severe acute pain associated with a long bone fracture in patients presenting to the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label pilot study.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	TRV130	Drug

Timeline

• Start date: 2015-10-20
• Primary completion: 2015-10-23
• Completion: 2015-10-23
• First posted: 2015-08-11
• Last updated: 2020-09-07
• Results posted: 2020-09-07

Locations

1 site across 1 country: United States